Blick ins Buch

Drug Safety in Clinical Practice

Peter I. Folb (Autor)

Buch | Softcover

XII, 196 Seiten

1983 | 1. Softcover reprint of the original 1st ed. 1984
Springer Berlin (Verlag)
978-3-540-12811-3 (ISBN)

Lese- und Medienproben

Inhaltsverzeichnis (PDF)

Artikel merken

Drugs may cause disease, or they may aggravate the morbidity of the condition for which they are prescribed, and certain patients may for one or other reason be particularly liable to drug injury. The inextricable relationships between the toxic profiles of drugs, the natural history of the diseases for which they are given, and the adverse drug effects that may develop in the course of such diseases are of considerable interest. It is the study of these rather neglected aspects of pharmacology and therapeutics which has formed the basis of this book. An explanation is required of the approach and the style which have been followed. The monograph does not purport to be comprehensive. Only important drug groups which are commonly used in practice are considered. Emphasis has been placed on achieving maximum benefit and safety of the appropriate drugs in the management of common illnesses. When treatment fails, either ab initio or subsequent to an initial response, the risk-benefit relationship of drugs inevitably alters. For this reason the main factors responsible for treatment failure have been considered, with special attention to the possible contribution of or implications for drug therapy in such a situation. Finally, proposals have been put forward for improving the diagnosis and reporting of adverse drug effects. In order to be practical and, as far as possible, constructive it has been necessary for me to "take a position" on numerous issues.

1 Drugs in Common Use.- 1.1 Antibiotics.- 1.2 Antihistamines.- 1.3 Histamine2-Receptor Blocking Agents.- 1.4 Antacids.- 1.5 Laxatives.- 1.6 Antidiarrhoeal Agents.- 1.7 Aspirin and the Acidic Non-steroidal Anti-inflammatory Agents.- 1.8 Digitalis.- 1.9 Sympathomimetic Drugs.- 1.10 Alpha-Adrenoreceptor Blocking Agents.- 1.11 Beta-Adrenoreceptor Blocking Agents.- 1.12 Potassium Supplements.- 1.13 Nitrates.- 1.14 Calcium Antagonists.- 1.15 Benzodiazepines.- 1.16 Tricyclic Antidepressants.- 1.17 Methylphenidate.- 1.18 Anorectic Agents.- 1.19 Addition of Drugs to Intravenous Fluids.- 1.20 Parenteral Nutrition.- >1.21 Topical Corticosteroids.- 1.22 Methylene Blue.- 1.23 Vitamins.- 2 Drug Safety in Some Common Medical Conditions.- 2.1 Heart Failure.- 2.2 Hypertension.- 2.3 Cough.- 2.4 Bronchial Asthma.- 2.5 Tuberculosis and Other Mycobacterial Infections.- 2.6 Fungal Infections.- 2.7 Malaria.- 2.8 Urinary Tract Infections.- 2.9 Cancer Chemotherapy.- 2.10 Iron-Deficiency Anaemia.- 2.11 Diabetes Mellitus.- 2.12 Gout.- 2.13 Myasthenia Gravis.- 3 Patients at Special Risk.- 3.1 Pregnant Women.- 3.2 Breast-Feeding mothers.- 3.3 The Elderly.- 3.4 Motor Vehicle Drivers.- 3.5 Porphyrics.- 4 Drug Injuries.- 4.1 Drug Fever.- 4.2 Anaphylaxis and Anaphylactoid Reactions.- 4.3 Drug-Induced Diseases of the Skin.- 4.4 Drug-Induced Vasculitis.- 4.5 Drug-Induced Vomiting.- 4.6 Central Anticholinergic Syndromes.- 4.7 Drug-Induced Ototoxicity.- 5 Diagnosing Adverse Drug Reactions.- Classification; probability of association; severity; Berkson's bias.

Erscheint lt. Verlag	1.12.1983
Zusatzinfo	XII, 196 p. 2 illus.
Verlagsort	London
Sprache	englisch
Maße	152 x 229 mm
Gewicht	360 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
Themenwelt	Medizin / Pharmazie ► Pharmazie ► PTA / PKA
Schlagworte	Arzneimittel • Arzneimittelnebenwirkung • Arzneitherapie • Arzneitherapie / Arzneibehandlung • Drug • Nebenwirkung • pharmacology • Wirkung
ISBN-10	3-540-12811-5 / 3540128115
ISBN-13	978-3-540-12811-3 / 9783540128113
Zustand	Neuware